img

Global Plasma Protease C1-inhibitor Treatment Market Research Report 2024

Published on: 2024-01-04 | No of Pages : 400 | Industry : Medical

Publisher : MRA | Format : PDF

Global Plasma Protease C1-inhibitor Treatment Market Research Report 2024

This report on the plasma protease C1-inhibitors treatment market analyzes the current and future scenario of the global market. Large number of acute HAE patients is increasing the usage of plasma protease C1-inhibitors treatment. Increasing prevalence of rare diseases around the world, promising pipeline drugs and novel therapies, rising investments in innovation of inhibitor drugs and increasing HAE awareness programs are the major drivers of the global plasma protease C1-inhibitors treatment market.
According to MRAResearch’s new survey, global Plasma Protease C1-inhibitor Treatment market is projected to reach US$ 9897.1 million in 2033, increasing from US$ 3173.4 million in 2022, with the CAGR of 17.3% during the period of 2023 to 2033. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Plasma Protease C1-inhibitor Treatment market research.
Based on drug class, the market has been segmented into C1-inhibitors (C1-esterase Inhibitor, Recombinant Inhibitor); Kallikrein Inhibitor (Kalbitor); Selective Bradykinin B2 Receptor Antagonist (Firazyr). The drug class market segments have been analyzed based on available approved products, cost-effectiveness, and preference given by the physicians for the treatment of HAE patients.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2033), aims to help readers to get a comprehensive understanding of global Plasma Protease C1-inhibitor Treatment market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.



By Company


Takeda
CSL
Sanquin
Pharming Group
Segment by Type
C1-inhibitors
Kallikrein Inhibitor (Kalbitor)

Segment by Application


Hospital Pharmacies
Independent Pharmacies and Outlets
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
The Plasma Protease C1-inhibitor Treatment report covers below items
Chapter 1Product Basic Information (Definition, Type and Application)
Chapter 2Global market size, regional market size. Market Opportunities and Challenges
Chapter 3Companies’ Competition Patterns
Chapter 4Product Type Analysis
Chapter 5Product Application Analysis
Chapter 6 to 10Country Level Value Analysis
Chapter 11Companies' Outline
Chapter 12Market Conclusions
Chapter 13Research Methodology and Data Source

Table of Content

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Plasma Protease C1-inhibitor Treatment Market Size Growth Rate by Type: 2018 VS 2022 VS 2033
1.2.2 C1-inhibitors
1.2.3 Kallikrein Inhibitor (Kalbitor)
1.3 Market by Application
1.3.1 Global Plasma Protease C1-inhibitor Treatment Market Growth by Application: 2018 VS 2022 VS 2033
1.3.2 Hospital Pharmacies
1.3.3 Independent Pharmacies and Outlets
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Plasma Protease C1-inhibitor Treatment Market Perspective (2018-2033)
2.2 Plasma Protease C1-inhibitor Treatment Growth Trends by Region
2.2.1 Global Plasma Protease C1-inhibitor Treatment Market Size by Region: 2018 VS 2022 VS 2033
2.2.2 Plasma Protease C1-inhibitor Treatment Historic Market Size by Region (2018-2023)
2.2.3 Plasma Protease C1-inhibitor Treatment Forecasted Market Size by Region (2024-2033)
2.3 Plasma Protease C1-inhibitor Treatment Market Dynamics
2.3.1 Plasma Protease C1-inhibitor Treatment Industry Trends
2.3.2 Plasma Protease C1-inhibitor Treatment Market Drivers
2.3.3 Plasma Protease C1-inhibitor Treatment Market Challenges
2.3.4 Plasma Protease C1-inhibitor Treatment Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Plasma Protease C1-inhibitor Treatment Players by Revenue
3.1.1 Global Top Plasma Protease C1-inhibitor Treatment Players by Revenue (2018-2023)
3.1.2 Global Plasma Protease C1-inhibitor Treatment Revenue Market Share by Players (2018-2023)
3.2 Global Plasma Protease C1-inhibitor Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Plasma Protease C1-inhibitor Treatment Revenue
3.4 Global Plasma Protease C1-inhibitor Treatment Market Concentration Ratio
3.4.1 Global Plasma Protease C1-inhibitor Treatment Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Plasma Protease C1-inhibitor Treatment Revenue in 2022
3.5 Plasma Protease C1-inhibitor Treatment Key Players Head office and Area Served
3.6 Key Players Plasma Protease C1-inhibitor Treatment Product Solution and Service
3.7 Date of Enter into Plasma Protease C1-inhibitor Treatment Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Plasma Protease C1-inhibitor Treatment Breakdown Data by Type
4.1 Global Plasma Protease C1-inhibitor Treatment Historic Market Size by Type (2018-2023)
4.2 Global Plasma Protease C1-inhibitor Treatment Forecasted Market Size by Type (2024-2033)
5 Plasma Protease C1-inhibitor Treatment Breakdown Data by Application
5.1 Global Plasma Protease C1-inhibitor Treatment Historic Market Size by Application (2018-2023)
5.2 Global Plasma Protease C1-inhibitor Treatment Forecasted Market Size by Application (2024-2033)
6 North America
6.1 North America Plasma Protease C1-inhibitor Treatment Market Size (2018-2033)
6.2 North America Plasma Protease C1-inhibitor Treatment Market Growth Rate by Country: 2018 VS 2022 VS 2033
6.3 North America Plasma Protease C1-inhibitor Treatment Market Size by Country (2018-2023)
6.4 North America Plasma Protease C1-inhibitor Treatment Market Size by Country (2024-2033)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Plasma Protease C1-inhibitor Treatment Market Size (2018-2033)
7.2 Europe Plasma Protease C1-inhibitor Treatment Market Growth Rate by Country: 2018 VS 2022 VS 2033
7.3 Europe Plasma Protease C1-inhibitor Treatment Market Size by Country (2018-2023)
7.4 Europe Plasma Protease C1-inhibitor Treatment Market Size by Country (2024-2033)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Plasma Protease C1-inhibitor Treatment Market Size (2018-2033)
8.2 Asia-Pacific Plasma Protease C1-inhibitor Treatment Market Growth Rate by Region: 2018 VS 2022 VS 2033
8.3 Asia-Pacific Plasma Protease C1-inhibitor Treatment Market Size by Region (2018-2023)
8.4 Asia-Pacific Plasma Protease C1-inhibitor Treatment Market Size by Region (2024-2033)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Plasma Protease C1-inhibitor Treatment Market Size (2018-2033)
9.2 Latin America Plasma Protease C1-inhibitor Treatment Market Growth Rate by Country: 2018 VS 2022 VS 2033
9.3 Latin America Plasma Protease C1-inhibitor Treatment Market Size by Country (2018-2023)
9.4 Latin America Plasma Protease C1-inhibitor Treatment Market Size by Country (2024-2033)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Plasma Protease C1-inhibitor Treatment Market Size (2018-2033)
10.2 Middle East & Africa Plasma Protease C1-inhibitor Treatment Market Growth Rate by Country: 2018 VS 2022 VS 2033
10.3 Middle East & Africa Plasma Protease C1-inhibitor Treatment Market Size by Country (2018-2023)
10.4 Middle East & Africa Plasma Protease C1-inhibitor Treatment Market Size by Country (2024-2033)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Takeda
11.1.1 Takeda Company Detail
11.1.2 Takeda Business Overview
11.1.3 Takeda Plasma Protease C1-inhibitor Treatment Introduction
11.1.4 Takeda Revenue in Plasma Protease C1-inhibitor Treatment Business (2018-2023)
11.1.5 Takeda Recent Development
11.2 CSL
11.2.1 CSL Company Detail
11.2.2 CSL Business Overview
11.2.3 CSL Plasma Protease C1-inhibitor Treatment Introduction
11.2.4 CSL Revenue in Plasma Protease C1-inhibitor Treatment Business (2018-2023)
11.2.5 CSL Recent Development
11.3 Sanquin
11.3.1 Sanquin Company Detail
11.3.2 Sanquin Business Overview
11.3.3 Sanquin Plasma Protease C1-inhibitor Treatment Introduction
11.3.4 Sanquin Revenue in Plasma Protease C1-inhibitor Treatment Business (2018-2023)
11.3.5 Sanquin Recent Development
11.4 Pharming Group
11.4.1 Pharming Group Company Detail
11.4.2 Pharming Group Business Overview
11.4.3 Pharming Group Plasma Protease C1-inhibitor Treatment Introduction
11.4.4 Pharming Group Revenue in Plasma Protease C1-inhibitor Treatment Business (2018-2023)
11.4.5 Pharming Group Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Figure

List of Tables
Table 1. Global Plasma Protease C1-inhibitor Treatment Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2033
Table 2. Key Players of C1-inhibitors
Table 3. Key Players of Kallikrein Inhibitor (Kalbitor)
Table 4. Global Plasma Protease C1-inhibitor Treatment Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2033
Table 5. Global Plasma Protease C1-inhibitor Treatment Market Size by Region (US$ Million): 2018 VS 2022 VS 2033
Table 6. Global Plasma Protease C1-inhibitor Treatment Market Size by Region (2018-2023) & (US$ Million)
Table 7. Global Plasma Protease C1-inhibitor Treatment Market Share by Region (2018-2023)
Table 8. Global Plasma Protease C1-inhibitor Treatment Forecasted Market Size by Region (2024-2033) & (US$ Million)
Table 9. Global Plasma Protease C1-inhibitor Treatment Market Share by Region (2024-2033)
Table 10. Plasma Protease C1-inhibitor Treatment Market Trends
Table 11. Plasma Protease C1-inhibitor Treatment Market Drivers
Table 12. Plasma Protease C1-inhibitor Treatment Market Challenges
Table 13. Plasma Protease C1-inhibitor Treatment Market Restraints
Table 14. Global Plasma Protease C1-inhibitor Treatment Revenue by Players (2018-2023) & (US$ Million)
Table 15. Global Plasma Protease C1-inhibitor Treatment Market Share by Players (2018-2023)
Table 16. Global Top Plasma Protease C1-inhibitor Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Plasma Protease C1-inhibitor Treatment as of 2022)
Table 17. Ranking of Global Top Plasma Protease C1-inhibitor Treatment Companies by Revenue (US$ Million) in 2022
Table 18. Global 5 Largest Players Market Share by Plasma Protease C1-inhibitor Treatment Revenue (CR5 and HHI) & (2018-2023)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Plasma Protease C1-inhibitor Treatment Product Solution and Service
Table 21. Date of Enter into Plasma Protease C1-inhibitor Treatment Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Plasma Protease C1-inhibitor Treatment Market Size by Type (2018-2023) & (US$ Million)
Table 24. Global Plasma Protease C1-inhibitor Treatment Revenue Market Share by Type (2018-2023)
Table 25. Global Plasma Protease C1-inhibitor Treatment Forecasted Market Size by Type (2024-2033) & (US$ Million)
Table 26. Global Plasma Protease C1-inhibitor Treatment Revenue Market Share by Type (2024-2033)
Table 27. Global Plasma Protease C1-inhibitor Treatment Market Size by Application (2018-2023) & (US$ Million)
Table 28. Global Plasma Protease C1-inhibitor Treatment Revenue Market Share by Application (2018-2023)
Table 29. Global Plasma Protease C1-inhibitor Treatment Forecasted Market Size by Application (2024-2033) & (US$ Million)
Table 30. Global Plasma Protease C1-inhibitor Treatment Revenue Market Share by Application (2024-2033)
Table 31. North America Plasma Protease C1-inhibitor Treatment Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 32. North America Plasma Protease C1-inhibitor Treatment Market Size by Country (2018-2023) & (US$ Million)
Table 33. North America Plasma Protease C1-inhibitor Treatment Market Size by Country (2024-2033) & (US$ Million)
Table 34. Europe Plasma Protease C1-inhibitor Treatment Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 35. Europe Plasma Protease C1-inhibitor Treatment Market Size by Country (2018-2023) & (US$ Million)
Table 36. Europe Plasma Protease C1-inhibitor Treatment Market Size by Country (2024-2033) & (US$ Million)
Table 37. Asia-Pacific Plasma Protease C1-inhibitor Treatment Market Size Growth Rate by Region (US$ Million): 2018 VS 2022 VS 2033
Table 38. Asia-Pacific Plasma Protease C1-inhibitor Treatment Market Size by Region (2018-2023) & (US$ Million)
Table 39. Asia-Pacific Plasma Protease C1-inhibitor Treatment Market Size by Region (2024-2033) & (US$ Million)
Table 40. Latin America Plasma Protease C1-inhibitor Treatment Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 41. Latin America Plasma Protease C1-inhibitor Treatment Market Size by Country (2018-2023) & (US$ Million)
Table 42. Latin America Plasma Protease C1-inhibitor Treatment Market Size by Country (2024-2033) & (US$ Million)
Table 43. Middle East & Africa Plasma Protease C1-inhibitor Treatment Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 44. Middle East & Africa Plasma Protease C1-inhibitor Treatment Market Size by Country (2018-2023) & (US$ Million)
Table 45. Middle East & Africa Plasma Protease C1-inhibitor Treatment Market Size by Country (2024-2033) & (US$ Million)
Table 46. Takeda Company Detail
Table 47. Takeda Business Overview
Table 48. Takeda Plasma Protease C1-inhibitor Treatment Product
Table 49. Takeda Revenue in Plasma Protease C1-inhibitor Treatment Business (2018-2023) & (US$ Million)
Table 50. Takeda Recent Development
Table 51. CSL Company Detail
Table 52. CSL Business Overview
Table 53. CSL Plasma Protease C1-inhibitor Treatment Product
Table 54. CSL Revenue in Plasma Protease C1-inhibitor Treatment Business (2018-2023) & (US$ Million)
Table 55. CSL Recent Development
Table 56. Sanquin Company Detail
Table 57. Sanquin Business Overview
Table 58. Sanquin Plasma Protease C1-inhibitor Treatment Product
Table 59. Sanquin Revenue in Plasma Protease C1-inhibitor Treatment Business (2018-2023) & (US$ Million)
Table 60. Sanquin Recent Development
Table 61. Pharming Group Company Detail
Table 62. Pharming Group Business Overview
Table 63. Pharming Group Plasma Protease C1-inhibitor Treatment Product
Table 64. Pharming Group Revenue in Plasma Protease C1-inhibitor Treatment Business (2018-2023) & (US$ Million)
Table 65. Pharming Group Recent Development
Table 66. Research Programs/Design for This Report
Table 67. Key Data Information from Secondary Sources
Table 68. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Plasma Protease C1-inhibitor Treatment Market Size Comparison by Type (2023-2033) & (US$ Million)
Figure 2. Global Plasma Protease C1-inhibitor Treatment Market Share by Type: 2022 VS 2033
Figure 3. C1-inhibitors Features
Figure 4. Kallikrein Inhibitor (Kalbitor) Features
Figure 5. Global Plasma Protease C1-inhibitor Treatment Market Size Comparison by Application (2023-2033) & (US$ Million)
Figure 6. Global Plasma Protease C1-inhibitor Treatment Market Share by Application: 2022 VS 2033
Figure 7. Hospital Pharmacies Case Studies
Figure 8. Independent Pharmacies and Outlets Case Studies
Figure 9. Plasma Protease C1-inhibitor Treatment Report Years Considered
Figure 10. Global Plasma Protease C1-inhibitor Treatment Market Size (US$ Million), Year-over-Year: 2018-2033
Figure 11. Global Plasma Protease C1-inhibitor Treatment Market Size, (US$ Million), 2018 VS 2022 VS 2033
Figure 12. Global Plasma Protease C1-inhibitor Treatment Market Share by Region: 2022 VS 2033
Figure 13. Global Plasma Protease C1-inhibitor Treatment Market Share by Players in 2022
Figure 14. Global Top Plasma Protease C1-inhibitor Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Plasma Protease C1-inhibitor Treatment as of 2022)
Figure 15. The Top 10 and 5 Players Market Share by Plasma Protease C1-inhibitor Treatment Revenue in 2022
Figure 16. North America Plasma Protease C1-inhibitor Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 17. North America Plasma Protease C1-inhibitor Treatment Market Share by Country (2018-2033)
Figure 18. United States Plasma Protease C1-inhibitor Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 19. Canada Plasma Protease C1-inhibitor Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 20. Europe Plasma Protease C1-inhibitor Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 21. Europe Plasma Protease C1-inhibitor Treatment Market Share by Country (2018-2033)
Figure 22. Germany Plasma Protease C1-inhibitor Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 23. France Plasma Protease C1-inhibitor Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 24. U.K. Plasma Protease C1-inhibitor Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 25. Italy Plasma Protease C1-inhibitor Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 26. Russia Plasma Protease C1-inhibitor Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 27. Nordic Countries Plasma Protease C1-inhibitor Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 28. Asia-Pacific Plasma Protease C1-inhibitor Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 29. Asia-Pacific Plasma Protease C1-inhibitor Treatment Market Share by Region (2018-2033)
Figure 30. China Plasma Protease C1-inhibitor Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 31. Japan Plasma Protease C1-inhibitor Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 32. South Korea Plasma Protease C1-inhibitor Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 33. Southeast Asia Plasma Protease C1-inhibitor Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 34. India Plasma Protease C1-inhibitor Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 35. Australia Plasma Protease C1-inhibitor Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 36. Latin America Plasma Protease C1-inhibitor Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 37. Latin America Plasma Protease C1-inhibitor Treatment Market Share by Country (2018-2033)
Figure 38. Mexico Plasma Protease C1-inhibitor Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 39. Brazil Plasma Protease C1-inhibitor Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 40. Middle East & Africa Plasma Protease C1-inhibitor Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 41. Middle East & Africa Plasma Protease C1-inhibitor Treatment Market Share by Country (2018-2033)
Figure 42. Turkey Plasma Protease C1-inhibitor Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 43. Saudi Arabia Plasma Protease C1-inhibitor Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 44. Takeda Revenue Growth Rate in Plasma Protease C1-inhibitor Treatment Business (2018-2023)
Figure 45. CSL Revenue Growth Rate in Plasma Protease C1-inhibitor Treatment Business (2018-2023)
Figure 46. Sanquin Revenue Growth Rate in Plasma Protease C1-inhibitor Treatment Business (2018-2023)
Figure 47. Pharming Group Revenue Growth Rate in Plasma Protease C1-inhibitor Treatment Business (2018-2023)
Figure 48. Bottom-up and Top-down Approaches for This Report
Figure 49. Data Triangulation
Figure 50. Key Executives Interviewed

Select User License

$4200 Single Licence
$6000 Enterprise Licence
$9100 Corporate Licence
Note : All prices in USD

FAQ'S

User License?

For a single, multi and corporate client license, the report will be available in PDF format. Sample report would be given you in excel format. For more questions please contact:

sales@mraccuracyreports.com

Within 24 to 48 hrs.

You can contact Sales team (sales@mraccuracyreports.com) and they will direct you on email

You can order a report by selecting payment methods, which is bank wire or online payment through any Debit/Credit card, Razor pay or PayPal.

Discounts are available.

Hard Copy

Email

Top Industries